Parade Technologies partners with UGREEN on flagship USB4 hub chipset solution
Bitget2026/10/06 13:03Parade Technologies struck a supply partnership with UGREEN to power UGREEN’s flagship USB4 hub with Parade’s PS9010 and PS5513 controllers. Deal positions Parade’s USB-IF certified USB4 dock silicon as the core platform for a mass-market peripheral expansion product. PS9010 is already in mass production, supporting near-term revenue conversion tied to UGREEN’s hub rollout. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Parade Technologies Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610060900BIZWIRE_USPR_____20261006_BW089949) on October 06, 2026, and is solely responsible for the information contained therein.
- Parade Technologies struck a supply partnership with UGREEN to power UGREEN’s flagship USB4 hub with Parade’s PS9010 and PS5513 controllers.
- Deal positions Parade’s USB-IF certified USB4 dock silicon as the core platform for a mass-market peripheral expansion product.
- PS9010 is already in mass production, supporting near-term revenue conversion tied to UGREEN’s hub rollout.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.